Cellular therapy in cardiology;La thérapie cellulaire en cardiologie

Comptes Rendus - Biologies

Volumn 330, Issue 6-7, 2007, Pages 550-556

  Menasché, Philippe ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Bone marrow; Cell therapy; Embryonic stem cells; Heart failure; Myoblasts; Myocardial infarction

Indexed keywords

CARDIOLOGY; CARDIOVASCULAR DISEASE;

ACUTE HEART INFARCTION; ANGINA PECTORIS; ANGIOGENESIS; ARTICLE; CARDIOLOGY; CELL DIFFERENTIATION; CELL POPULATION; CELL REGENERATION; CELL TRANSFER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; EMBRYONIC STEM CELL; ENGRAFTMENT; GRAFT SURVIVAL; HEART FAILURE; HEART FUNCTION; HEART MUSCLE CELL; HEMATOPOIETIC STEM CELL; HUMAN; MEDICAL RESEARCH; OUTCOME ASSESSMENT; PARACRINE SIGNALING; RANDOMIZED CONTROLLED TRIAL; STEM CELL TRANSPLANTATION; TISSUE REGENERATION; TREATMENT INDICATION; TREATMENT OUTCOME;

ANIMALS; HEART DISEASES; HUMANS; MYOCYTES, CARDIAC; RANDOMIZED CONTROLLED TRIALS; STEM CELL TRANSPLANTATION;

ANGINA;

EID: 34447325658     PISSN: 16310691     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crvi.2007.05.004     Document Type: Article

References (46)

1. Hagege A.A., Marolleau J.-P., Vilquin J.-T., Alhéritière A., Peyrard S., Duboc D., Abergel E., Messas E., Mousseaux E., Schwartz K., Desnos M., and Menasché P. Skeletal myoblast transplantation in ischemic heart failure: Long-term follow-up of the first phase I cohort of patients. Circulation 114 Suppl. 1 (2006) I108-I113
2. Gavira J.J., Herreros J., Perez A., Garcia-Velloso M.J., Barba J., Martin-Herrero F., Canizo C., Martin-Arnau A., Marti-Climent J.M., Hernandez M., Lopez-Holgado N., Gonzalez-Santos J.M., Martin-Luengo C., Alegria E., and Prosper F. Autologous skeletal myoblast transplantation in patients with nonacute myocardial infarction: 1-year follow-up. J. Thorac. Cardiovasc. Surg. 131 (2006) 799-804
3. Dib N., Michler R.E., Pagani F.D., Wright S., Kereiakes D.J., Lengerich R., Binkley P., Buchele D., Anand I., Swingen C., Di Carli M.F., Thomas J.D., Jaber W.A., Opie S.R., Campbell A., McCarthy P., Yeager M., Dilsizian V., Griffith B.P., Korn R., Kreuger S.K., Ghazoul M., MacLellan W.R., Fonarow G., Eisen H.J., Dinsmore J., and Diethrich E. Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up. Circulation 112 (2005) 1748-1755
4. Siminiak T., Kalawski R., Fiszer D., Jerzykowska O., Rzezniczak J., Rozwadowska N., and Kurpisz M. Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: Phase I clinical study with 12 months offollow-up. Am. Heart J. 148 (2004) 531-537
5. Biagini E., Valgimigli M., Smits P.C., Poldermans D., Schinkel A.F., Rizzello V., Onderwater E.E., Bountioukos M., and Serruys P.W. Stress and tissue Doppler echocardiographic evidence of effectiveness of myoblast transplantation in patients with ischaemic heart failure. Eur. J Heart Fail. (2006) Feb 27
6. Ince H., Petzsch M., Rehders T.C., Chatterjee T., and Nienaber C.A. Transcatheter transplantation of autologous skeletal myoblasts in postinfarction patients with severe left ventricular dysfunction. J. Endovasc. Ther. 11 (2004) 695-704
7. Siminiak T., Kalawski R., Fiszer D., Jerzykowska O., Rzezniczak J., Rozwadowska N., and Kurpisz M. Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: Phase I clinical study with 12 months of follow-up. Am. Heart J. 148 (2004) 531-537
8. Janssens S., Dubois C., Bogaert J., Theunissen K., Deroose C., Desmet W., Kalantzi M., Herbots L., Sinnaeve P., Dens J., Maertens J., Rademakers F., Dymarkowski S., Gheysens O., Van Cleemput J., Bormans G., Nuyts J., Belmans A., Mortelmans L., Boogaerts M., and Van de Werf F. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: Double-blind, randomised controlled trial. Lancet 367 (2006) 113-121
9. Meyer G.P., Wollert K.C., Lotz J., Steffens J., Lippolt P., Fichtner S., Hecker H., Schaefer A., Arseniev L., Hertenstein B., Ganser A., and Drexler H. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (bone marrow transfer to enhance ST-elevation infarct regeneration) trial. Circulation 113 (2006) 1287-1294
10. Schachinger V., Erbs S., Elsasser A., Haberbosch W., Hambrecht R., Holschermann H., Yu J., Corti R., Mathey D.G., Hamm C.W., Suselbeck T., Assmus B., Tonn T., Dimmeler S., Zeiher A.M., and REPAIR-AMI Investigators. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N. Engl. J. Med. 355 (2006) 1210-1221
11. Lunde K., Solheim S., Aakhus S., Arnesen H., Abdelnoor M., Egeland T., Endresen K., Ilebekk A., Mangschau A., Fjeld J.G., Smith H.J., Taraldsrud E., Grogaard H.K., Bjornerheim R., Brekke M., Muller C., Hopp E., Ragnarsson A., Brinchmann J.E., and Forfang K. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N. Engl. J. Med. 355 (2006) 1199-1209
12. Erbs S., Linke A., Adams V., Lenk K., Thiele H., Diederich K.W., Emmrich F., Kluge R., Kendziorra K., Sabri O., Schuler G., and Hambrecht R. Transplantation of blood-derived progenitor cells after recanalization of chronic coronary artery occlusion: first randomized and placebo-controlled study. Circ. Res. 97 (2005) 756-762
13. Ripa R.S., Jorgensen E., Wang Y., Thune J.J., Nilsson J.C., Sondergaard L., Johnsen H.E., Kober L., Grande P., and Kastrup J. Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: Result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial. Circulation 113 (2006) 1983-1992
14. Zohlnhofer D., Ott I., Mehilli J., Schomig K., Michalk F., Ibrahim T., Meisetschlager G., von Wedel J., Bollwein H., Seyfarth M., Dirschinger J., Schmitt C., Schwaiger M., Kastrati A., Schomig A., and REVIVAL-2 Investigators. Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: A randomized controlled trial. JAMA 295 (2006) 1003-1010
15. Ince H., Petzsch M., Kleine H.D., Schmidt H., Rehders T., Korber T., Schumichen C., Freund M., and Nienaber C.A. Preservation from left ventricular remodeling by front-integrated revascularization and stem cell liberation in evolving acute myocardial infarction by use of granulocyte-colony-stimulating factor (FIRSTLINE-AMI). Circulation 112 (2005) 3097-3106
16. Mansour S., Vanderheyden M., De Bruyne B., Vandekerckhove B., Delrue L., Van Haute I., Heyndrickx G., Carlier S., Rodriguez-Granillo G., Wijns W., and Bartunek J. Intracoronary delivery of hematopoietic bone marrow stem cells and luminal loss of the infarct-related artery in patients with recent myocardial infarction. J. Am. Coll. Cardiol. 47 (2006) 1727-1730
17. Murry C.E., Reinecke H., and Pabon L.M. Regeneration gaps: observations on stem cells and cardiac repair. J. Am. Coll. Cardiol. 47 (2006) 1777-1785
18. Uemura R., Xu M., Ahmad N., and Ashraf M. Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ. Res. 98 (2006) 1414-1421
19. Mangi A.A., Noiseux N., Kong D., He H., Rezvani M., Ingwall J.S., and Dzau V.J. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat. Med. 9 (2003) 1195-1201
20. Tang Y.L., Zhao Q., Qin X., Shen L., Cheng L., Ge J., and Phillips M.I. Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction. Ann. Thorac. Surg. 80 (2005) 229-236 discussion 236-237
21. Misao Y., Takemura G., Arai M., Sato S., Suzuki K., Miyata S., Kosai K., Minatoguchi S., Fujiwara T., and Fujiwara H. Bone marrow-derived myocyte-like cells and regulation of repair-related cytokines after bone marrow cell transplantation. Cardiovasc. Res. 69 (2006) 476-490
22. Gnecchi M., He H., Liang O.D., Melo L.G., Morello F., Mu H., Noiseux N., Zhang L., Pratt R.E., Ingwall J.S., and Dzau V.J. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat. Med. 11 (2005) 367-368
23. Leobon B., Garcin I., Menasché P., Vilquin J.-T., Audinat E., and Charpak S. Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc. Natl Acad. Sci. USA 100 (2003) 7808-7811
24. Lagostena L., Avitabile D., De Falco E., Orlandi A., Grassi F., Iachininoto M.G., Ragone G., Fucile S., Pompilio G., Eusebi F., Pesce M., and Capogrossi M.C. Electrophysiological properties of mouse bone marrow c-kit+ cells co-cultured onto neonatal cardiac myocytes. Cardiovasc. Res. 66 (2005) 482-492
25. Murry C.E., Soonpaa M.H., Reinecke H., Nakajima H., Nakajima H.O., Rubart M., Pasumarthi K.B., Virag J.I., Bartelmez S.H., Poppa V., Bradford G., Dowell J.D., Williams D.A., and Field L.J. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428 (2004) 664-668
26. Balsam L.B., Wagers A.J., Christensen J.L., Kofidis T., Weissman I.L., and Robbins R.C. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428 (2004) 668-673
27. Dow J., Simkhovich B.Z., Kedes L., and Kloner R.A. Washout of transplanted cells from the heart: A potential new hurdle for cell transplantation therapy. Cardiovasc. Res. 67 (2005) 301-307
28. Freyman T., Polin G., Osman H., Crary J., Lu M., Cheng L., Palasis M., and Wilensky R.L. A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur. Heart J. 27 (2006) 1114-1122
29. Memon I.A., Sawa Y., Fukushima N., Matsumiya G., Miyagawa S., Taketani S., Sakakida S.K., Kondoh H., Aleshin A.N., Shimizu T., Okano T., and Matsuda H. Repair of impaired myocardium by means of implantation of engineered autologous myoblast sheets. J. Thorac. Cardiovasc. Surg. 130 (2005) 1333-1341
30. Maurel A., Azarnoush K., Sabbah L., Vignier N., Le Lorc'h M., Mandet C., Bissery A., Garcin I., Carrion C., Fiszman M., Bruneval P., Hagege A., Carpentier A., Vilquin J.T., and Menasché P. Can cold or heat shock improve skeletal myoblast engraftment in infracted myocardium?. Transplantation 80 (2005) 660-665
31. Yau T.M., Li G., Weisel R.D., Reheman A., Jia Z.Q., Mickle D.A., and Li R.K. Vascular endothelial growth factor transgene expression in cell-transplanted hearts. J. Thorac. Cardiovasc. Surg. 127 (2004) 1180-1187
32. Azarnoush K., Maurel A., Sebbah L., Carrion C., Bissery A., Mandet C., Pouly J., Bruneval P., Hagege A.A., and Menasché P. Enhancement of the functional benefits of skeletal myoblast transplantation by means of coadministration of hypoxia-inducible factor 1 alpha. J. Thorac. Cardiovasc. Surg. 130 (2005) 173-179
33. Memon I.A., Sawa Y., Miyagawa S., Taketani S., and Matsuda H. Combined autologous cellular cardiomyoplasty with skeletal myoblasts and bone marrow cells in canine hearts for ischemic cardiomyopathy. J. Thorac. Cardiovasc. Surg. 130 (2005) 646-653
34. Davis M.E., Motion J.P., Narmoneva D.A., Takahashi T., Hakuno D., Kamm R.D., Zhang S., and Lee R.T. Injectable self-assembling peptide nanofibers create intramyocardial microenvironments for endothelial cells. Circulation 111 (2005) 442-450
35. Hsieh P.C., Davis M.E., Gannon J., MacGillivray C., and Lee R.T. Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers. J. Clin. Invest. 116 (2006) 237-248
36. Stuckey D.J., Carr C.A., Martin-Rendon E., Tyler D.J., Willmott C., Cassidy P.J., Hale S.J., Schneider J.E., Tatton L., Harding S.E., Radda G.K., Watt S., and Clarke K. Iron particles for noninvasive monitoring of bone marrow stromal cell engraftment into, and isolation of viable engrafted donor cells from, the heart. Stem Cells 24 (2006) 1968-1975
37. Rubart M., Pasumarthi K.B., Nakajima H., Soonpaa M.H., Nakajima H.O., and Field L.J. Physiological coupling of donor and host cardiomyocytes after cellular transplantation. Circ. Res. 92 (2003) 1217-1224
38. Winitsky S.O., Gopal T.V., Hassanzadeh S., Takahashi H., Gryder D., Rogawski M.A., Takeda K., Yu Z.X., Xu Y.H., and Epstein N.D. Adult murine skeletal muscle contains cells that can differentiate into beating cardiomyocytes in vitro. PLoS Biol. 3 (2005) e87
39. Yoon Y.S., Wecker A., Heyd L., Park J.S., Tkebuchava T., Kusano K., Hanley A., Scadova H., Qin G., Cha D.H., Johnson K.L., Aikawa R., Asahara T., and Losordo D.W. Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J. Clin. Invest. 115 (2005) 326-338
40. Planat-Benard V., Ménard C., André M., Puceat M., Perez A., Garcia-Verdugo J.M., Penicaud L., and Casteilla L. Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells. Circ. Res. 94 (2004) 223-229
41. Leor J., Guetta E., Feinberg M.S., Galski H., Bar I., Holbova R., Miller L., Zarin P., Castel D., Barbash I.M., and Nagler A. Human umbilical cord blood-derived CD133+ cells enhance function and repair of the infarcted myocardium. Stem Cells 24 3 (2006) 772-780
42. Parmacek M.S., and Epstein J.A. Pursuing cardiac progenitors: regeneration redux. Cell (2005) 295-298
43. Hodgson D.M., Behfar A., Zingman L.V., Kane G.C., Perez-Terzic C., Alekseev A.E., Puceat M., and Terzic A. Stable benefit of embryonic stem cell therapy in myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 287 (2004) H471-H479
44. Ménard C., Hagege A.A., Agbulut O., Barro M., Morichetti M.-C., Brasselet C., Bel A., Messas E., Bissery A., Bruneval P., Desnos M., Puceat M., and Menasché P. Transplantation of cardiac-committed mouse embryonic stem cells to infracted sheep myocardium: A preclinical study. Lancet 366 (2005) 1005-1012
45. Kehat I., Khimovich L., Caspi O., Gepstein A., Shofti R., Arbel G., Huber I., Satin J., Itskovitz-Eldor J., and Gepstein L. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat. Biotechnol. 22 (2004) 1282-1289
46. Taylor C.J., Bolton E.M., Pocock S., Sharples L.D., Pedersen R.A., and Bradley J.A. Banking on human embryonic stem cells: Estimating the number of donor cell lines needed for HLA matching. Lancet 366 (2005) 2019-2025